4 ms·
Moderna shares double on melanoma vaccine trial success
- ChrisArchitect 1mo agoRelated: Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma https://news.ycombinator.com/item?id=49361395 https://news.ycombinator.com/item?id=49361395